Literature DB >> 17945193

Microarray analysis of hepatic gene expression in pyrazole-mediated hepatotoxicity: identification of potential stimuli of Cyp2a5 induction.

Kathleen D Nichols1, Gordon M Kirby.   

Abstract

Cytochrome P450 2a5 (Cyp2a5) expression is induced during liver damage caused by hepatotoxins such as pyrazole, however, the mechanism underlying this overexpression is unclear. In order to identify pathophysiological and cellular responses to pyrazole that might alter Cyp2a5 expression, we examined the effect of pyrazole on mouse hepatic gene expression in C57BL/6 mice using Affymetrix 430 2.0 microarrays. Over 3000 differentially expressed genes were identified 24-h after pyrazole treatment that were associated with a variety of cellular pathways. Upregulated genes were primarily involved in the splicing and processing of RNA and the unfolded protein response pathway, while downregulated genes were associated with amino acid and lipid metabolism, and generation of precursor metabolites for energy production. We also examined the effects of pyrazole on cellular pathways linked to metabolic and histopathological changes observed with pyrazole toxicity. Increased mRNA levels were observed for genes involved in bilirubin production, whereas the major genes of the urea cycle were strongly decreased. Changes in genes involved in carbohydrate metabolism were also observed which could explain pyrazole-induced glycogen depletion and decreased serum glucose. In addition, over 100 genes involved in the cellular stress response were upregulated by pyrazole treatment, including genes involved in the unfolded protein response and redox status. Based on these results and previous evidence concerning the regulation of Cyp2a5, we have identified several pathophysiological changes including altered energy homeostasis, hyperbilirubinemia, ER stress, and altered redox status that are associated with CYP2A5 overexpression and may represent potential stimuli for the induction of Cyp2a5.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945193     DOI: 10.1016/j.bcp.2007.09.009

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Differences in the rate of nicotine metabolism among smokers with and without HIV.

Authors:  Rebecca L Ashare; Morgan Thompson; Frank Leone; David Metzger; Robert Gross; Karam Mounzer; Rachel F Tyndale; Caryn Lerman; Martin C Mahoney; Paul Cinciripini; Tony P George; Ronald G Collman; Robert Schnoll
Journal:  AIDS       Date:  2019-05-01       Impact factor: 4.177

2.  Ethanol induction of CYP2A5: permissive role for CYP2E1.

Authors:  Yongke Lu; Jian Zhuge; Defeng Wu; Arthur I Cederbaum
Journal:  Drug Metab Dispos       Date:  2010-11-04       Impact factor: 3.922

3.  In vivo study of hepatitis B vaccine effects on inflammation and metabolism gene expression.

Authors:  Heyam Hamza; Jianhua Cao; Xinyun Li; Shuhong Zhao
Journal:  Mol Biol Rep       Date:  2011-06-21       Impact factor: 2.316

4.  Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish Larvae.

Authors:  Yun Zhang; Kechun Liu; Hozeifa M Hassan; Hongli Guo; Pingping Ding; Liwen Han; Qiuxia He; Weiyun Chen; Chung-Der Hsiao; Luyong Zhang; Zhenzhou Jiang
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

5.  Discernment of possible mechanisms of hepatotoxicity via biological processes over-represented by co-expressed genes.

Authors:  Jeff W Chou; Pierre R Bushel
Journal:  BMC Genomics       Date:  2009-06-18       Impact factor: 3.969

6.  Inhibition of the mitochondrial permeability transition by cyclosporin A prevents pyrazole plus lipopolysaccharide-induced liver injury in mice.

Authors:  Jian Zhuge; Arthur I Cederbaum
Journal:  Free Radic Biol Med       Date:  2008-10-31       Impact factor: 7.376

7.  Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: low-dose effects and non-monotonic dose-response relationship.

Authors:  Ana C A X De-Oliveira; Kátia S Poça; Paulo R R Totino; Francisco J R Paumgartten
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

8.  Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver.

Authors:  Katia S Poça; Thiago E M Parente; Lucas F Chagas; Bruna S Leal; Hellen S Leal; Francisco J R Paumgartten; Ana C A X De-Oliveira
Journal:  BMC Res Notes       Date:  2017-03-15

9.  Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease.

Authors:  Craig D Fisher; Andrew J Lickteig; Lisa M Augustine; James Ranger-Moore; Jonathan P Jackson; Stephen S Ferguson; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2009-08-03       Impact factor: 3.922

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.